Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis

Michael Krowka; Emmanuelle Cottreel; Marius M. Hoeper; Nick H. Kim; Nicolas Martin; Olivier Sitbon; Jaume Bosch

doi:10.1002/lt.25747

Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis

Michael Krowka, Emmanuelle Cottreel, Marius M. Hoeper, Nick H. Kim, Nicolas Martin, Olivier Sitbon, Jaume Bosch

Pulmonary and Critical Care Medicine

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	935-940
Number of pages	6
Journal	Liver Transplantation
Volume	26
Issue number	7
DOIs	https://doi.org/10.1002/lt.25747
State	Published - Jul 1 2020

ASJC Scopus subject areas

Surgery
Hepatology
Transplantation

Access to Document

10.1002/lt.25747

Cite this

@article{d20204c9124547dcb7ede605b34d5c0f,

title = "Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis",

author = "Michael Krowka and Emmanuelle Cottreel and Hoeper, {Marius M.} and Kim, {Nick H.} and Nicolas Martin and Olivier Sitbon and Jaume Bosch",

note = "Funding Information: Medical writing assistance and editorial support were provided by Zoe Schafer, Ph.D. (Watermeadow Medical, an Ashfield company, part of UDG Healthcare plc) and was funded by Actelion Pharmaceuticals, Ltd. The authors thank Jonathan Tolson (Clinical Scientist, Actelion Pharmaceuticals, Ltd.) for his role in the PORTICO study.",

year = "2020",

month = jul,

day = "1",

doi = "10.1002/lt.25747",

language = "English (US)",

volume = "26",

pages = "935--940",

journal = "Liver Transplantation",

issn = "1527-6465",

publisher = "John Wiley and Sons Ltd",

number = "7",

}

TY - JOUR

T1 - Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension

T2 - A PORTICO Study Post Hoc Analysis

AU - Krowka, Michael

AU - Cottreel, Emmanuelle

AU - Hoeper, Marius M.

AU - Kim, Nick H.

AU - Martin, Nicolas

AU - Sitbon, Olivier

AU - Bosch, Jaume

N1 - Funding Information: Medical writing assistance and editorial support were provided by Zoe Schafer, Ph.D. (Watermeadow Medical, an Ashfield company, part of UDG Healthcare plc) and was funded by Actelion Pharmaceuticals, Ltd. The authors thank Jonathan Tolson (Clinical Scientist, Actelion Pharmaceuticals, Ltd.) for his role in the PORTICO study.

PY - 2020/7/1

Y1 - 2020/7/1

UR - http://www.scopus.com/inward/record.url?scp=85084215755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084215755&partnerID=8YFLogxK

U2 - 10.1002/lt.25747

DO - 10.1002/lt.25747

M3 - Letter

C2 - 32150762

AN - SCOPUS:85084215755

SN - 1527-6465

VL - 26

SP - 935

EP - 940

JO - Liver Transplantation

JF - Liver Transplantation

IS - 7

ER -

Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this